Navigation Links
Attention Regado Biosciences, Inc. Investors: Regado Misled Investors According to a Recently Filed Class Action
Date:7/14/2014

SAN DIEGO & BASKING RIDGE, N.J., July 14, 2014 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP announces that an investor of Regado Biosciences, Inc. (NASDAQ: RGDO) has filed a federal securities fraud class action complaint in the U.S. District Court for the District of New Jersey.  The complaint alleges that the company and certain of its officers and directors violated the Securities Exchange Act of 1934 between August 22, 2013 and July 9, 2014 (the "Class Period").  Regado is a biopharmaceutical company that focuses on the discovery and development of antithrombotic drug systems for acute and sub-acute cardiovascular and other indications.

Regado Is Accused of Misrepresenting Revolixys™ Kit Clinical Trail

According to the complaint, shares of Regado fell multiple times, beginning with an initial decline of $3.95 per share, or over 58%, to close at $2.81 on July 3, 2014 following an announcement by the company that it was voluntarily suspending the Phase 3 trial of its Revolixys™ Kit, known as REG1, an anticoagulant intended for use in patients with a wide variety of acute coronary syndromes, following a review of the Data Safety Monitoring Board to determine the safety and treatment benefit-risk ratio of the 3,234 patients enrolled in the study. Shortly thereafter, on July 9, 2014, Regado shares fell an addition $0.19 per share, or 7%, to close at $2.51 on July 10, 2014 following a subsequent announcement by the company that the U.S. Federal Drug Administration placed a hold on all patient enrollment and dosing in the Phase 3 trial of REG1. 

The complaint further alleges that Regado knew and failed to disclose that its REG1 Phase 3 trial patients were experiencing frequent and severe allergic reactions that would ultimately require the trial to be suspended.

Regado Investors Are Encouraged to Contact Shareholder Rights Law Firm Robbins Arroyo LLP

If you invested in Regado and would like to discuss your shareholder rights, please contact attorney Darnell R. Donahue at (800) 350-6003, DDonahue@robbinsarroyo.com, or via the information form on the firm's shareholder rights blog: https://www.robbinsarroyo.com/shareholders-rights-blog/regado-biosciences-inc/

Robbins Arroyo LLP is a nationally recognized leader in securities litigation and shareholder rights law.  The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. 

Attorney Advertising. Past results do not guarantee a similar outcome.  

Contact:
Darnell R. Donahue
Robbins Arroyo LLP
DDonahue@robbinsarroyo.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsarroyo.com

Logo - http://photos.prnewswire.com/prnh/20130103/MM36754LOGO


'/>"/>
SOURCE Robbins Arroyo LLP
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Maroon 5 Lead Singer Adam Levine and Shire Announce "The Own It Project," Encouraging Adults with Attention-Deficit/Hyperactivity Disorder to Tell Their Stories Through a National Contest
2. Texas Medicaid Managed-Care Problems Gaining National Attention
3. Attention Veterans: New Medtech Job Training Program Accepting Applications through Friday, August 31
4. More than Morning Sickness: Kate Middletons Pregnancy Announcement Draws Attention to Rare Pregnancy Condition Known as Hyperemesis Gravidarum (HG)
5. GC-Rise Attracts Attention in Health Capital Market
6. Hepatitis Awareness: Bringing Attention to a Silent Epidemic
7. Attention Gates Foundation: Alsa Refinish Requests Your Help to Reduce Needle Use Worldwide
8. Regado Biosciences, Inc. to Present at the 2012 Wedbush PacGrow Life Sciences Conference in New York, NY
9. Regado Biosciences, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference in Boston, MA
10. Regado Biosciences, Inc. to Present at the UBS Global Life Sciences Conference 2012 in New York, NY
11. Regado Biosciences, Inc. to Present at the Oppenheimer 23rd Annual Healthcare Conference in New York, NY
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2019)... (PRWEB) , ... August 19, 2019 , ... ... announce that Spiro Khoury, M.D., will join its Richardson, Texas location, starting Monday, ... American Board of Anesthesiology with a subspecialty board certification in pain management. , ...
(Date:8/16/2019)... ... August 16, 2019 , ... Healthpointe is ... and Reprocessing therapy (EMDR). This therapeutic technique aims to reduce psychological distress, promote ... post-traumatic stress disorder (PTSD), depression, chronic pain, anxiety, and grief. EMDR is ...
(Date:8/16/2019)... Ga. (PRWEB) , ... August 16, 2019 , ... ... Bridge Road in Gainesville GA, 30501, is a comprehensive family dental practice that ... those within general dentistry, cosmetic dentistry , endodontics and restorative dental care. ...
Breaking Medicine Technology:
(Date:8/16/2019)... ... August 16, 2019 , ... Cannabinoid Biosciences (“CBDZ”), ... cannabidiol (CBD) products across the CBD market in the United States in particular ... to raise $50 million on September 9, 2019. , Established on May 6, ...
(Date:8/16/2019)... MANHEIM, Pa. (PRWEB) , ... August 16, 2019 ... ... of other construction safety professionals from throughout the Mid-Atlantic and North East at ... two-day interactive forum was engineered to build on existing construction safety concepts and ...
(Date:8/15/2019)... ... August 15, 2019 , ... ... pathology residents who have been directly affected by the closure of Hahnemann University ... donations gathered during the campaign, the ASCP Foundation will be making hardship grants ...
(Date:8/15/2019)... ... August 15, 2019 , ... Heritage Woods of Rockford Administrator Jaclyn O’Keefe has ... , This award is part of the NCAL Awards Program, which recognizes exemplary assisted ... element among this year’s recipients is that they all go out of their way ...
(Date:8/14/2019)... ... August 14, 2019 , ... ScribeAmerica, the ... has earned a place on the Inc. magazine 500/5000 list today for the ... a decade of ScribeAmerica’s recognition as one of the fastest growing companies in ...
Breaking Medicine News(10 mins):